Wu X - Search Results

1

Circulating adipokine concentrations and risk of five obesity-related cancers: A Mendelian randomization study.

Dimou NL, Papadimitriou N, Mariosa D, Johansson M, Brennan P, Peters U, Chanock SJ, Purdue M, Bishop DT, Gago-Dominquez M, Giles GG, Moreno V, Platz EA, Tangen CM, Wolk A, Zheng W, Wu X, Campbell PT, Giovannucci E, Lin Y; CCFR, Endometrial Cancer Association Consortium; Gunter MJ, Murphy N. Dimou NL, et al. Among authors: wu x. Int J Cancer. 2021 Apr 1;148(7):1625-1636. doi: 10.1002/ijc.33338. Epub 2020 Oct 26. Int J Cancer. 2021. PMID: 33038280 Free PMC article.

2

A case-control analysis of lymphocytic chromosome 9 aberrations in lung cancer.

Zhu Y, Spitz MR, Strom S, Tomlinson GE, Amos CI, Minna JD, Wu X. Zhu Y, et al. Among authors: wu x. Int J Cancer. 2002 Dec 10;102(5):536-40. doi: 10.1002/ijc.10762. Int J Cancer. 2002. PMID: 12432559 Free article.

3

XRCC3 genetic polymorphism, smoking, and lung carcinoma risk in minority populations.

Wang Y, Liang D, Spitz MR, Zhang K, Dong Q, Amos CI, Wu X. Wang Y, et al. Among authors: wu x. Cancer. 2003 Oct 15;98(8):1701-6. doi: 10.1002/cncr.11692. Cancer. 2003. PMID: 14534887 Free article.

4

Hormone replacement therapy and lung cancer risk: a case-control analysis.

Schabath MB, Wu X, Vassilopoulou-Sellin R, Vaporciyan AA, Spitz MR. Schabath MB, et al. Among authors: wu x. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):113-23. doi: 10.1158/1078-0432.ccr-0911-3. Clin Cancer Res. 2004. PMID: 14734459

5

Methyl-CpG-binding domain 2: a protective role in bladder carcinoma.

Zhu Y, Spitz MR, Zhang H, Grossman HB, Frazier ML, Wu X. Zhu Y, et al. Among authors: wu x. Cancer. 2004 May 1;100(9):1853-8. doi: 10.1002/cncr.20199. Cancer. 2004. PMID: 15112265 Free article.

6

Increased plasma levels of angiogenin and the risk of bladder carcinoma: from initiation ot recurrence.

Zhao H, Grossman HB, Delclos GL, Hwang LY, Troisi CL, Chamberlain RM, Chenoweth MA, Zhang H, Spitz MR, Wu X. Zhao H, et al. Among authors: wu x. Cancer. 2005 Jul 1;104(1):30-5. doi: 10.1002/cncr.21136. Cancer. 2005. PMID: 15912517 Free article.

7

Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.

Minard CG, Spitz MR, Wu X, Hong WK, Etzel CJ. Minard CG, et al. Among authors: wu x. Cancer. 2006 Jun 15;106(12):2636-44. doi: 10.1002/cncr.21928. Cancer. 2006. PMID: 16703596 Free article. Clinical Trial.

8

Bladder cancer risk as modified by family history and smoking.

Lin J, Spitz MR, Dinney CP, Etzel CJ, Grossman HB, Wu X. Lin J, et al. Among authors: wu x. Cancer. 2006 Aug 15;107(4):705-11. doi: 10.1002/cncr.22071. Cancer. 2006. PMID: 16845665 Free article.

9

Matrix metalloproteinase polymorphisms and bladder cancer risk.

Kader AK, Shao L, Dinney CP, Schabath MB, Wang Y, Liu J, Gu J, Grossman HB, Wu X. Kader AK, et al. Among authors: wu x. Cancer Res. 2006 Dec 15;66(24):11644-8. doi: 10.1158/0008-5472.CAN-06-1212. Cancer Res. 2006. PMID: 17178858

10

Irradiation-induced telomerase activity and the risk of lung cancer: a pilot case-control study.

Chen M, Gu J, Xing J, Spitz MR, Wu X. Chen M, et al. Among authors: wu x. Cancer. 2007 Mar 15;109(6):1157-63. doi: 10.1002/cncr.22493. Cancer. 2007. PMID: 17265522 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54,819 results

Search Page